High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type I vector

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 278-287

  Wang, Minghui ^a   Rancourt, Claudine ^a   Navarro, Jesus G ^a   Krisky, David ^b   Marconi, Peggy ^b   Oligino, Thomas ^b   Alvarez, Ronald D ^a   Siegal, Gene P ^a   Glorioso, Joseph C ^b   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE; VIRUS VECTOR;

ARTICLE; CANCER CHEMOTHERAPY; CELL KILLING; DNA SYNTHESIS INHIBITION; DRUG EFFICACY; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; SUICIDE GENE; VIRUS REPLICATION;

EID: 0032213847     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5132     Document Type: Article

References (40)

1. Parkin D M, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594-606.
2. Tenereillo M G, Park R C. Early detection of ovarian cancer. CA Cancer J Clin. 45:1995;71-87.
3. Moolten F. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res. 46:1986;5276-5281.
4. Mullen C A, Kilstrup M, Blaese R M. Transfer of the bacterial gene for cytosine deaminase to mammalian cell confer lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA. 89:1992;33-37.
5. Elion G B, Furman P A, Fyfe J A, DeMiranda P, Beauchamp L, Schaeffer H J. Selectivity of action of an antiherpetic agent 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci USA. 74:1977;5716-5720.
6. Furman P A, Mcgujirt P V, Keller P M, Fyfe J A, Elion G B. Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemical transformed with herpesvirus genetic information. Virology. 102:1980;420-430.
7. Freeman S M, Abboud C N, Whartenby K A, Packman CH Ko, Elin D S, Moolten F L, Abraham G N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53:1993;5274-5283.
8. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA. 93:1996;1831-1835.
9. Rosenfeld M E, Feng M, Micheal S I, Siegal G P, Alvarez R D, Curiel D T. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Clin Cancer Res. 1:1995;1571-1580.
10. Blaese M, Blankenstein T, Brenner M. Vectors in cancer therapy: how will they deliver? Cancer Gene Ther. 2:1995;291-297.
11. Wang S, Vos J M. A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cellsin vitroin vivo. J Virol. 70:1996;8422-8430.
12. Stevens J G. Human herpesviruses: a consideration of the latent state. Microbiol Rev. 53:1989;318-332.
13. Miyanohara A, Jonhson P A, Elam R L. Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. New Biol. 4:1992;238-246.
14. Huard J, Glorioso J C. Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther. 2:1995;385-392.
15. Smiley J F, Smibert C, Everett R D. Expression of a cellular gene cloned in herpes simples virus: rabbit β-globin is regulated as an early gene in infected fibroblasts. J Virol. 61:1987;2368-2377.
16. Coffin R S, Howard M K, Cumming D V, Dollery C M. Gene delivery to the heartin vivoin vitro. Gene Ther. 3:1996;560-566.
17. Kucharczuk J C, Randazzo B, Chang M Y, Amin K M. Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma. Cancer Res. 57:1997;466-471.
18. Dilloo D, Rill D, Entwistle C, Boursnell M, Zhong W, Holden W. A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells. Blood. 89:1997;119-127.
19. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci USA. 93:1996;11307-11312.
20. DeLuca N A, McCarthy A M, Schaffer P A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol. 56:1985;558-570.
21. Marconi P, Krisky D, Oligino T, Poliani P L, Ramakrishnan R. Replication-defective herpes simplex virus vectors for gene transferin vivo. Proc Natl Acad Sci USA. 93:1996;11319-11320.
22. Samaniego L A, Webb A L, DeLuca N A. Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol. 69:1995;5705-5715.
23. Wu N, Watkins S C, Schaffer P A, Deluca N A. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol. 70:1996;6358-6369.
24. Krisky, D, M, Marconi, P, C, Ramalrishnan, R, Mata, M, Rouse, R, JD, Fink, D, J, Glorioso, J, C, Deletion of multiple immediate early genes from herpes simplex virus reduces cytotoxicity and improves gene transfer to neurons in culture, J Virol.
25. Rasty S, Goins W F, Glorioso J C. Site-Specific Integration of Multigenic Shuttle Plasmids into Herpes Simplex Virus Type 1 (HSV-1) Genome Using a Cell-Free Cre-lox Recombination System. Methods in Molecular Genetics. 1995;Academic Press, New York. p. 114-130.
26. Hamada K, Alemany R, Zhang W W, Hittelman W N, Lotan R, Roth J A, Mitchell M F. Adenovirus-mediated transfer of a wild-type p53 and induction of apoptosis in cervical cancer. Cancer Res. 56:1996;3047-3054.
27. Wickham T J, Roelvink P W, Brough D E, Kovesdi I. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotechnol. 14:1996;1570-1573.
28. v3v5. Cell. 73:1993;309-319.
29. Spear P G. Entry of alphaviruses into cells. Semin Virol. 4:1993;167-180.
30. Fuller A O, Lee W C. Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J Virol. 66:1992;5002-5012.
31. Gruenheid S, Gatzke L, Meadows H, Tufaro F. Herpes simplex virus infection and propagation in a mouse L-cell mutant lacking heparan sulfate proteoglycans. J Virol. 67:1993;93-100.
32. WuDunn D, Spear P G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol. 63:1989;52-58.
33. White J M. Integrins as virus receptors. Curr Biol. 3:1993;596-599.
34. Brunetti C R, Burke R L, Kornfeld S, Gregory W, Masiarzi F R, Dingwell K S, Johnson D C. Herpes simplex virus glycoprotein D acquires mannose 6-phosphate residues and binds to mannose 6-phosphate receptors. J Biol Chem. 269:1994;17067-17074.
35. Marsters S A, Ayres T M, Skubatch M, Gray C L, Rohte M, Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem. 272:1997;14029-14032.
36. Johnson P A, Wang M J, Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J Virol. 68:1994;6347-6362.
37. Whitley R J. Herpes Simplex Viruses. Fields B N, Knipe D M. Virology. 1990;1843 Raven Press, New York.
38. Oligino T, Poliani P L, Marconi P, Bender M A, Schmidt M C, Fink D J, Glorioso J C. In vivo. Gene Ther. 3:1996;892-899.
39. Elshami A A, Cook J W, Amin K M, Choi H, Park J Y. The effect of promoter strengh in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapyin vitroin vivo. Cancer Gene Ther. 4:1997;213-221.
40. Hoganson D K, Batra R K, Olsen J C, Boucher R C. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and the bystander effect in lung adenocarcinoma. Cancer Res. 56:1996;1315-1323.